Introduction {#s1}
============

The first developmental events in mouse are subject to regulation by information stored in the oocyte. The maternal inheritance in oocytes consists of mRNAs and proteins, which together direct rapid epigenetic reprogramming upon fertilisation, cell cleavage and activation of the zygotic genome ([@bib1]; [@bib17]; [@bib36]).

The process of maternal-to-zygotic transition (MZT) in mice is first initiated in the late zygote, becoming more prominent at 2 cell stage (2C) on embryonic day (E) 1.5 ([@bib8]; [@bib9]; [@bib24]). The initial wave of activation of many genes is followed by their repression within one or two cell cycles ([@bib7]; [@bib9]). How multiple genes are faithfully repressed during early embryogenesis to promote developmental progression remains unclear.

Extensive remodelling of the histone modifications and DNA methylation accompany division of blastomeres, which suggests a role for epigenetic regulatory mechanisms during development of the first embryonic lineages ([@bib5]; [@bib18]; [@bib29]; [@bib34]; [@bib38]; [@bib41]; [@bib42]). Outer trophectoderm (TE) cells are the first to be allocated together with the inner cell mass cells (ICM) at the blastocyst stage (E3.5). Shortly afterwards, by E4.0, the ICM segregates into primitive endoderm cells (PrE) and the pluripotent pre-Epiblast cells (Epi), which will give rise to the yolk sac and embryo proper respectively ([@bib4]; [@bib28]).

We extend our previous study on the role of G9a-mediated H3K9me2 in mouse early post-implantation development ([@bib43]), and examined the role of this histone methyltransferase during preimplantation development. We show that G9a (encoded by *Ehmt2* gene) is maternally inherited and drives the accumulation of H3K9me2 at 4C and 8C stage, which accounts for timely repression of a subset of transcripts expressed at 4C. Severe disruption of the gene regulatory network follows upon maternal loss of G9a, resulting in developmental delay and destabilisation of ICM lineages, and frequent loss of embryos at the peri-implantation stage. Altogether, our results indicate that maternally-inherited G9a is crucial for regulating appropriate gene expression changes during preimplantation development.

Results and discussion {#s2}
======================

G9a and H3K9me2 accumulate at 4 and 8 cell stage {#s2-1}
------------------------------------------------

First, we investigated the H3K9me2 dynamics in early mouse preimplantation development. Immunofluorescence (IF) analysis of 2C (E1.5), 4C (E2.0), 8C (E2.5) and late blastocysts (E4.5) revealed progressive and significant accumulation of H3K9me2 at 4C and 8C stage; this was not the case at 2C or at E4.5 ([Figure 1A,B](#fig1){ref-type="fig"}). A more substantial enrichment follows in the epiblast of postimplantation embryos ([@bib43]).

![H3K9me2 and G9a accumulate at 4- and 8 cell stage.\
(**A**) Whole-mount IF staining for H3K9me2 (top panels) and G9a (bottom panels) in E1.5, E2.0, E2.5 and E4.5 embryos. DAPI intensity has been adjusted between time points for visualisation purposes (scale bar = 20 μm). IF signal is quantified (**B**) and visualised using box plots of median and interquartile range (IQR), with whiskers drawn 1.5xIQR away from the lower and upper quartiles. Data shows IF intensity normalised to DAPI for individual cells. At least 9 embryos were quantified for each time point. (\*p\<0.05 by Wilcoxon rank sum test). 2C: 2 cell stage; 4C: 4 cell stage; 8C: 8 cell stage; DAPI: 4\',6-diamidino-2-phenylindole; H3K9me2: histone H3 lysine 9 dimethylation; IF: immunofluorescence; IQR: interquartile range. Also see [Figure 1---figure supplements 1](#fig1s1){ref-type="fig"} and [2](#fig1s2){ref-type="fig"}.](elife-33361-fig1){#fig1}

The first wave of H3K9 dimethylation is consistent with increased level of G9a at 4C, and more significantly so at 8C stage ([Figure 1A,B](#fig1){ref-type="fig"}). What is more, G9a's binding partner GLP also accumulates in 8C embryos ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). These results, in line with a previous immunofluorescence study ([@bib16]), indicate that even low levels of nuclear G9a at 4C stage are sufficient to initiate H3K9 dimethylation. Thus, following the burst of transcription at 2C stage, blastomeres accumulate substantial levels of repressive H3K9me2 mark, although its functional significance remains unclear.

G9a promotes developmental progression and primitive endoderm (PrE) segregation {#s2-2}
-------------------------------------------------------------------------------

To determine the role of G9a in preimplantation development, we first induced depletion of the maternal pool of both the *Ehmt2* transcript and G9a protein in the oocyte ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). To do so, we used *Zp3-Cre*-expressing *Ehmt2^F/-^* females (*Ehmt2^F/+^* for controls), in which conditional allele is recombined under Cre recombinase expression during oogenesis ([@bib6]), and crossed them with *Ehmt2^+/-^* males. Whereas loss of both maternal and zygotic G9a (*Ehmt2^M/Z^*) does not appear to grossly affect early development up to the E2.5 stage, these embryos show slight developmental delay and lack of substantial accumulation of H3K9me2 ([Figure 2A,B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Upon further development in vitro, the maternally depleted embryos do form blastocysts (E4.5), however with fewer *Pou5f1*-positive ICM cells ([Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}).

![Lack of maternal G9a leads to smaller blastocysts with fewer PrE cells.\
(**A**) Whole-mount IF staining for G9a and H3K9me2 in E2.5 *Ehmt2^M/Z^* and *Ehmt2^M/+^* embryos. (Scale bar = 20 μm). (**B**) IF signal quantification for G9a and H3K9me2 from [Figure 2A](#fig2){ref-type="fig"}. Box plots show median and interquartile range (IQR), with whiskers drawn 1.5xIQR away from the lower and upper quartiles. Data shows IF intensity normalised to DAPI. At least six embryos were quantified for each genotype. (\*p\<0.05 in Wilcoxon rank sum test). (**C**) Whole-mount IF staining of E4.5 *Ehmt2^Mat^* and *Ehmt2^Cntr^* blastocysts using anti-CDX2 (TE, Blue), anti-SOX2 (Epi, Green) and anti-SOX17 (PrE, Red) antibodies. White arrows point towards nuclei devoid of staining for any lineage marker. (Scale bar = 20 μm). (**D--F**) Dot plots showing IF quantification from [Figure 2C](#fig2){ref-type="fig"} in relation to embryo genotypes. Each dot represents one embryo, 10 *Ehmt2^Mat^* and 8 *Ehmt2^Cntr^* embryos were quantified. (**D**) Total number of cells in an embryo. (**E**) Percentage of cells within the ICM (SOX2^+^ or SOX17^+^). (**F**) Percentage of cells within each lineage or showing no marker gene expression (SOX2^-^SOX17^-^CDX2^-^). Line shows the median. (\*p\<0.05 in Wilcoxon rank sum test). CDX2: Caudal Type Homeobox 2; DAPI: 4\',6-diamidino-2-phenylindole; *Ehmt2^Cntr^*: control embryos with maternally inherited G9a; *Ehmt2^M/+^* embryos maternally depleted but with zygotic expression of G9a; *Ehmt2^M/Z^* embryos without both maternal and zygotic expression of G9a; *Ehmt2^Mat^* embryos maternally depleted of G9a;Epi: pre-epiblast; H3K9me2: histone H3 lysine 9 dimethylation; ICM: inner cell mass; IF: immunofluorescence; IQR: interquartile range; PrE: primitive endoderm; SOX2: SRY box 2; SOX17: SRY box 17; TE: trophectoderm. Also see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.](elife-33361-fig2){#fig2}

Next, we performed a detailed IF analysis of mutant and control embryos recovered at E4.5 for SOX2, SOX17 and CDX2, the critical markers of epiblast (Epi), primitive endoderm (PrE) and trophectoderm (TE), respectively ([Figure 2C](#fig2){ref-type="fig"}). We found no significant difference concerning lineage allocation between *Ehmt2^M/Z^* and *Ehmt2^M/+^* embryos and thus decided to group them together as maternally depleted embryos (*Ehmt2^Mat^*). Similarly, control embryos (*Ehmt2^Cntr^*) of different genotypes (e.g. *Ehmt2^+/-^* vs *Ehmt2^-/-^*, data not shown) also do not reveal detectable phenotypic differences at E4.5. In contrast, *Ehmt2^Mat^* compared to *Ehmt2^Cntr^* blastocysts show significantly reduced cell numbers (80 vs 166 cells, respectively), and with fewer ICM (SOX2^+ve^ or SOX17^+ve^) cells (25.0% vs 39.1% respectively) in line with our initial observation ([Figure 2D,E](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}). We attribute the changes primarily to a relative reduction in PrE cells (7.9% vs 25.3%), as well as to a relative increase in the ICM cells that do not display expression of any of the three lineage markers ([Figure 2F](#fig2){ref-type="fig"}).

This observation suggests that maternal loss of G9a results in delayed development and lineage segregation within the ICM. The observed phenotype is however not entirely due to a developmental delay since we also see defects in lineage stabilisation within the ICM, potentially resulting in cell loss. Consistently, when comparing *Ehmt2^Mat^* and *Ehmt2^Cntr^* blastocysts we observed a significant increase in the levels γH2A.X, a hallmark of genetic stress and misregulation of the cell cycle ([Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}) ([@bib33]). Accumulation of γH2A.X also occurs in cells with decondensed chromatin potentially due to loss of H3K9me2 ([@bib2]). Notably, 'knockdown' of GLP, a binding partner of G9a, also results in defects in blastocyst, increased cell death, and loss of cells in the ICM ([@bib10]). Thus, G9a-GLP complex likely promotes developmental progression in vivo, with a timely specification of the PrE and stabilisation of lineage choices. The significant reduction in the number of cells in mutant embryos as well as accumulation of γH2A.X indicate potential misregulation of the cell cycle as we reported in the postimplantation epiblast ([@bib43]). Nevertheless, mutant embryos show defects in timely lineage segregation and stabilisation at the blastocyst stage, which indicates that epigenetic programming might create conditions conducive to cell fate choices. Previous studies have similarly indicated that arginine methylation by CARM1 and PRDM14, might also be important for the establishment of the Epi ([@bib3]; [@bib32]). We thus hypothesise that maternal G9a is involved in setting up a stable transcriptional and epigenetic network allowing for timely developmental progression and lineage segregation at the blastocyst stage.

G9a represses a subset of 4C upregulated genes {#s2-3}
----------------------------------------------

To address the functional relevance of G9a in transcriptional regulation, we focused on the 8C stage (E2.5), when we detect accumulation of the highest levels of G9a and H3K9me2. Loss of maternal G9a at 8C has yet to result in an overt phenotype except for a mild developmental delay. To determine if there are underlying consequences of loss of G9a already at 8C, we performed single-embryo RNA-seq on ten control (*Ehmt2^Cntr^*), and ten maternally depleted embryos (*Ehmt2^Mat^*), which were morphologically indistinguishable ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). Of note, we observed differential expression of only six genes between *Ehmt2^M/Z^* and *Ehmt2^M/+^;* we decided therefore to group them together. Maternally depleted G9a embryos however are largely transcriptionally distinct from the controls as shown by principal component analysis (PCA) ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). The differential expression of 1467 genes accounts for the differences between the two groups, of which 44% become upregulated ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"}). Lack of enrichment for derepressed genes upon maternal loss of a transcriptional repressor implies that the transcriptome is affected prior to 8C, by which stage we observe substantial accumulation of secondary transcriptional effects. Interestingly, there were only four genes upregulated in both E2.5 *Ehmt2^Mat^* and E6.25 *Ehmt2^-/-^* embryos ([@bib43])(Chi2 p\>0.77; [Figure 3B](#fig3){ref-type="fig"}), indicating that G9a plays a distinct role in pre- and post-implantation development.

![Maternal G9a represses a subset of genes induced at 4 cell stage.\
(**A**) Scatter plot showing transcript expression levels in *Ehmt2^Cntr^* and *Ehmt2^Mat^* 8C (E2.5) stage embryos. Blue points are differentially expressed genes (adjusted p\<0.05 in DEseq2). Shown is the average from ten biological replicates. (**B**) Venn diagram showing the overlap between upregulated genes upon maternal loss of G9a (*Ehmt2^Mat^*) at 8C (E2.5) and those upregulated in zygotic *Ehmt2* deletion in E6.25 epiblast ([@bib43]). (**C**) Expression profiles of genes within specific clusters during wildtype development from 2C to 8C (left panels). Dotted line represents mean expression within the cluster. Data from GSE22182 ([@bib30]) was used and within all expressed genes 14 specific clusters were identified. Shown are clusters most enriched for genes becoming derepressed (Clusters 1 and 6) or downregulated (Cluster 11) at 8C in Ehmt2^Mat^. Right panel of bar plots shows the percentage of genes upregulated (Green) or downregulated (Red) at 8C in Ehmt2^Mat^, which belong to identified clusters. Significance of enrichments was calculated using Chi2 test (\* 10^−5^ \< p \< 0.05; \*\* 10^−10^ \< p \< 10^−5^; \*\*\*p\<10^−10^). (**D**) Fold expression changes of PrE (*Fgfr1, Gata6*, *Gata4*) and TE (*Tead4, Tfap2c*) marker genes in *Ehmt2^Mat^*compared to *Ehmt2^Cntr^* 8C embryos. Box plots show median and interquartile range (IQR), with whiskers drawn 1.5xIQR away from the lower and upper quartiles. Each dot is a single embryo and data was normalised to median expression levels in *Ehmt2^Cntr^*. (\*adjusted p\<0.05 in DEseq2). 2C: 2 cell embryo, 4C: 4 cell embryo; 8C: 8 cell embryo; *Ehmt2^Cntr^*: control embryos with maternally inherited G9a; *Ehmt2^Mat^* embryos maternally depleted of G9a; *Fgfr1*: fibroblast growth factor receptor 1; *Gata4*: GATA binding protein 4; *Gata6*: GATA binding protein 6; IQR: interquartile range; *Tcfap2c*: Transcription factor AP-2 gamma; TE: trophectoderm; *Tead4*: TEA domain transcription factor 4. Also see [Figure 3---figure supplements 1](#fig3s1){ref-type="fig"}--[3](#fig3s3){ref-type="fig"} and [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}--[3](#fig3sdata3){ref-type="supplementary-material"}.\
10.7554/eLife.33361.011Figure 3---source data 1.List of all single-embryo RNAseq samples sequenced.Shown are numbers of uniquely mapped reads as well as the genotype of each embryo.\
10.7554/eLife.33361.012Figure 3---source data 2.List of differentially expressed genes between Ehmt2^Cntr^ and Ehmt2^Mat^ at 8C stage embryos.Differentially expressed genes were identified using DEseq2 with adjusted p-value\<0.05.\
10.7554/eLife.33361.013Figure 3---source data 3.List of enriched GO terms in genes upregulated or downregulated in 8C Ehmt2^Mat^ embryos.GO term enrichment for biological processes was calculated using DAVID software with minimum five genes in a category and EASE p-value\<0.05.](elife-33361-fig3){#fig3}

For further insight into the role of G9a in regulating early development, we performed Gene Ontology (GO) enrichment analysis ([Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}). Consistent with the reduced blastocyst size and loss of ICM cells at E4.5, the GO terms indicated down regulation of genes involved in cell cycle (p\<10^−8^), transcription (p\<10^−4^) and stem cell population maintenance (p\<10^−4^), in *Ehmt2^Mat^* 8C embryos ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). However, the GO term most strikingly enriched was chromatin silencing (p\<10^−11^), which is entirely due to reduced levels of 18 transcripts coding for H2A, MacroH2A and H2A.J ([Figure 3---figure supplement 1B,C](#fig3s1){ref-type="fig"}). Invariably, these histones are already upregulated in a subset of *Ehmt2^Cntr^* embryos by E2.5, which is not the case in the mutants ([Figure 3---figure supplement 1D,E](#fig3s1){ref-type="fig"})([@bib37]). Thus, despite being morphologically indistinguishable from controls, *Ehmt2^Mat^* 8C embryos deviate from them concerning developmental progression. On the other hand, there was high enrichment of genes for GO terms such as rRNA processing (p\<10^−23^) and mRNA processing (p\<10^−17^) indicating that G9a preferentially represses genes linked to RNA metabolism ([Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}).

To put these results in the context of the developmental progression, we have integrated our results with an independent single-cell RNAseq dataset of wildtype mouse preimplantation embryos ([@bib30]). Firstly, we performed clustering of genes using Gaussian mixture fitting based on their dynamic expression between 2C and 8C stages ([@bib35]). To describe the expression dynamics, we found an optimal number of 14 clusters of genes. Next, we overlapped genes within clusters with those upregulated or downregulated at the 8C stage in *Ehmt2^Mat^* embryos ([Figure 3C](#fig3){ref-type="fig"}). Strikingly, of the upregulated genes, 28% and 30% were part of cluster 1 and 6, respectively (Chi^2^ \<10^−68^ and Chi^2^ \<10^−48^). Genes within those clusters are transiently upregulated at the 4C stage. On the other hand, cluster 11 of stably expressed genes, is most enriched for genes downregulated upon loss of maternal G9a (12% of genes, Chi2 \<10^−15^, [Figure 3C](#fig3){ref-type="fig"}). To further validate the specific derepression of 4C genes in mutants, we have also analysed gene expression changes between 2C and 4C, as well as 4C and 8C stages in wildtype embryos ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). Our analysis revealed that genes upregulated in *Ehmt2^Mat^* 8C embryos (green box), show a significant increase in expression at 4C stage, which are silenced later in wildtype embryos. Our findings indicate that during preimplantation development, G9a mediates silencing of a specific set of genes, which are transiently upregulated at 4C stages. Whereas there is significant accumulation of H3K9me2 globally as judged by IF analysis at the 4C stage ([Figure 1A,B](#fig1){ref-type="fig"}), the precise distribution of the mark within the genome cannot be ascertained by this observation. We propose that it is only at the 8C stage that the increasing levels of G9a levels allow H3K9me2 deposition at the 4C-specific genes.

Next, to explore the roots of lineage destabilisation in maternally depleted embryos, we focused on the misexpression of transcriptional factors (TFs) in our RNAseq dataset (n = 71) ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). Consistent with fewer PrE and more TE cells, there was a reduction in the levels of PrE specifiers (*Gata6*, *Fgfr1*), and an increase in the expression of TE markers (*Tead4, Tcfap2c*) in maternally deleted mutants compared to controls ([Figure 3D](#fig3){ref-type="fig"}). Intriguingly, expression of *Gata4,* normally seen in late blastocysts, already shows upregulation in mutant embryos ([@bib25]) ([Figure 3D](#fig3){ref-type="fig"}). These results indicate that maternal loss of G9a results in destabilisation of specific gene regulatory networks involved in pre-implantation development. Efficient setting up of such transcriptional circuitry as early as the 8C stage seems necessary for subsequent timely lineage segregation. However, it remains unclear which subset of the differentially expressed genes directly results in PrE defects. Indeed, this might be linked to increased expression of a critical trophectoderm specifier *Tead4* ([@bib39]), or downregulation of vital PrE regulators *Fgfr1* ([@bib12]; [@bib22]) and *Gata6* ([@bib27]). Alternatively, ICM cells might show increased sensitivity to the deregulation of such processes as RNA metabolism and cell cycle. Importantly, derepression of transposable elements (TE) might also result in increased DNA damage and cell death ([@bib1]).

To address the latter hypothesis, we performed differential TE expression analysis on our RNA-seq dataset. Of particular interest are murine endogenous retrovirus-like elements (MuERV-L), which were shown to be derepressed upon loss of G9a in embryonic stem cells (ESCs)([@bib21]). This class of TEs is transiently expressed at the 2C stage ([@bib13]; [@bib20]; [@bib24]) and regulates zygotic genome activation, transcriptional networks and developmenal progression ([@bib11]; [@bib13]). Our TE analysis of mutant embryos however revealed only a very mild reactivation of the ERV-L family of TEs, which contains MuERV-L ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Thus, G9a is dispensible for timely repression of these retrotransposons. We have however observed persistent H3K9me2 staning at DAPI-dense foci in *Ehmt2^M/Z^* at the 8C stage ([Figure 2A](#fig2){ref-type="fig"}), suggesting that another histone methyltransferase is likely to deposit silent chromatin marks at repetetive elements in the absence of G9a. Indeed, a recent study suggests that a loss of SETDB1, an H3K9 methyltransferase, results in upregulation of both ERV and LINE1 elements in oocytes ([@bib15]).

In conclusion, the role of G9a during preimplantation development is distinct from that observed during postimplantation development. Notably, G9a is required for the repression of a specific set of transiently upregulated 4C genes in preimplantation embryos. Moreover, maternal G9a allows for the appropriate setting of transcriptional circuits, which promote developmental progression, timely PrE specification and stabilisation of ICM lineages. Together with PRDM14 and arginine methylation reported previously ([@bib3]; [@bib32]), our findings suggest that the earliest epigenetic programming events at the onset of development are involved in creating a competent environment for cell fate choices that ensue. These epigenetic regulators, amongst others, ensure establishment of stable transcriptional circuitry, which instructs lineage segregation later in development.

Materials and methods {#s3}
=====================

  Reagent type (species) or resource   Designation      Source or reference
  ------------------------------------ ---------------- ---------------------
  Strain (mouse)                       Ehmt2Flox/Flox   PMID:17707231
  Strain (mouse)                       Zp3-Cre          PMID: 10686600

GO term enrichment analysis were performed exactly as in ([@bib43]).

Mouse breading, embryo collection {#s3-1}
---------------------------------

Timed natural matings were used for all experiments unless otherwise stated. Noon of the day when the vaginal plugs of mated females were identified was scored as E0.5. For *Ehmt2* matings a published conditional allele was used ([@bib26]). To obtain *Ehmt2^Cntr^* or *Ehmt2^Mat^* embryos, *Ehmt2^F/+^* Zp3-Cre^+ve^ or *Ehmt2^F/-^* Zp3-Cre^+ve^ females were used respectively ([@bib6]). When stated a *ΔPE-Pou5f1-EGFP* reporter line was crossed in (GGOF) ([@bib40]). All husbandry and experiments involving mice were carried out according to the local ethics committee and were performed in a facility designated by the Home Office.

Immunofluorescence {#s3-2}
------------------

Embryos were treated as previously described ([@bib23]). Primary antibodies used are as follows: anti-CDX2 (Biogenex, clone CDX2-88), anti-H3K9me2 (Abcam, UK, ab1220), anti-GFP (Nacalai tesque, Japan, GF090R), anti-G9a (Cell Signaling, MA, 68851T), anti-GLP (Research and Diagnostic Systems, MN, PP-B0422-00), anti-SOX2 (Abcam, UK, ab92494), anti-SOX17(Research and Diagnostic Systems, MN, AF1924). Mean nuclear intensities of IF and DAPI signal were quantified using mageJ and corrected for the staining background. As nuclear size is changing between stages all IF measurements were normalised to DAPI signal as a proxy for DNA content.

Single-Embryo RNAseq {#s3-3}
--------------------

The embryos used were from natural matings and were morphologically assessed to ensure only viable samples were collected. cDNA was prepared and amplified as earlier described ([@bib31]). Illumina libraries were prepared as published ([@bib11]). Single-end 50 bp sequencing was performed with HiSeq4000 (Illumina, San Diego, CA). RNA-seq reads were adapter- and quality-trimmed, and aligned with Tophat2 ([@bib14]) against the mouse reference (GRCm38/mm10) genome. Read counts per ENSEMBL transcript were obtained by SeqMonk. Differential expression was evaluated with the DESeq2 package ([@bib19]). Gene was deemed differentially expressed when p-value\<0.05 after Benjamini and Hochberg correction. For clustering the dynamics of gene expression in distinct environments we have used an R package GeneClusterNet based on Gaussian mixture fitting ([@bib35]). For this analysis data was downloaded from GEO (GSE22182) ([@bib30]). Optimal numbers of clusters (14) was identified by finding minimal Bayesian Information Criterion. For TE analysis, RNA-seq reads were aligned with *bowtie* (options: '-m 1 -- v1 \--best \--strata') selecting for uniquely mapping reads only. RepeatMasker annotations of individual TE elements were downloaded from the UCSC Table Browser. Read counts per TE elements were obtained by *featureCounts* (<http://bioinf.wehi.edu.au/featureCounts>). Data is available under GSE106790.
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Tang FBarbacioru CLao KSurani MA2010Global Deterministic and Stochastic Allelic Specific Gene Expression in Single Blastomeres of Mouse Early Embryos<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22182>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE22182).

Wu JHuang BChen HXie W2016The landscape of accessible chromatin in mammalian pre-implantation embryos (RNA-Seq)<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66582>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE66582).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"G9a regulates temporal preimplantation developmental program and lineage segregation in blastocyst\" for consideration by *eLife*. Your article has been favorably evaluated by Fiona Watt (Senior Editor) and two reviewers, one of whom, Asifa Akhtar (Reviewer \#1), is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

In this manuscript, authors study the functional consequence of the loss of maternally inherited G9a in blastocysts. Combination of immunofluorescence based image analysis and single embryo transcriptome analysis revealed that maternal loss of G9a results in misregulation of gene expression network leading to developmental delay. These data indicate that G9a mediated H3K9me2 is important for proper lineage commitment early in embryogenesis.

Although the reviewers find the manuscript interesting, it was discussed that the manuscript needs to be further strengthened by increasing the number of embryos analysed to be able to make more sound conclusions. In particular, the authors should address the following points upon revision:

\- Authors conclude that development is unaffected up to the 8-cell stage, but by E4.5 defects emerge. However no analysis of developmental competence is presented. A careful examination of developmental progression in *Ehmt2^Mat^* embryos with observed embryonic stages on each day from E0.5 to E4.5 would be most appropriate to firmly establish when developmental defects arise.

In Figure 1, authors state that at least 3 embryos and 15 nuclei used for analysis. These are very low numbers (embryos) to form reliable conclusions. They should increase the N numbers to cover at least 3 independent experiments and at least 10 embryos per group.

\- Immunostaining of H3K9me2 should also be performed at the 4-cell stage and morula stage to determine temporal dynamics of H3K9me2 in more detail. This is especially relevant in light of the results regarding derepression of 4-cell genes at the 8-cell stage in *Ehmt2^Mat^* embryos in Figure 3. The model proposed is that G9a is silencing genes between the 4-cell and 8-cell stage specifically (not before), which correlates with a global accumulation of H3K9me2. However this accumulation is only presented between the 2-cell and 8-cell stages here in Figure 1, not the 4-cell and 8-cell stages. If global accumulation of H3K9me2 is in fact occurring most prominently between the 2-cell and 4-cell stages the model proposed does not hold.

\- Also in Figure 2, only 4 embryos analysed, which is not enough for an appropriate analysis. At least 3 independent experiments (and at least 10 embryos per group) are required.

\- The authors conclude that there are fewer ICM cells in G9a-deficient blastocysts based on counting of Oct4-positive cells. However this conclusion is not fully supported by the results presented here. Please explain how this experiment was performed.

\- It would also be most informative to analyse these counts at both E3.5 as well as E4.5 to determine the timing of the effect (i.e. is ICM establishment at E3.5 or differentiation into PE vs. EPI at E4.5 affected in the absence of G9a?).

\- The authors state that the GO term most enriched in genes downregulated in *Ehmt2^Mat^* 8C embryos is chromatin silencing, which can be entirely explained by altered levels of H2A, MacroH2A and H2A.J transcripts. It is hard to believe that the strongest GO term enrichment with a highly significant p value can be entirely explained by 3 transcripts. Can the authors provide additional discussion/evidence for this?

\- Authors should expand on their observations that there is increase DNA damage in the absence of maternal G9a. It was not clear why this is the case?

\- Is there a way to experimentally address whether gene expression defects are a result of direct targeting of G9a to the promoters?

\- It was interesting to see that G9a dispensable for transposon repression. Is it possible to know whether upon G9a loss, SETDB1 gets upregulated to compensate?

Other points:

1\) Is the H3K9me2 antibody used specific for K9me2? Since most antibodies are known to cross-react with K9me3 and/or K9me1 -- it will be important that the authors discuss/provide a statement and/or data towards this effect.

2\) For the presentation of confocal images:

\- The scale bars are missing in a number of images (e.g. Figure 1A and B).

\- How was fluorescence intensity quantification carried out?

10.7554/eLife.33361.026

Author response

> \[...\] Although the reviewers find the manuscript interesting, it was discussed that the manuscript needs to be further strengthened by increasing the number of embryos analysed to be able to make more sound conclusions. In particular, the authors should address the following points upon revision:
>
> \- Authors conclude that development is unaffected up to the 8-cell stage, but by E4.5 defects emerge. However no analysis of developmental competence is presented. A careful examination of developmental progression in Ehmt2^Mat^ embryos with observed embryonic stages on each day from E0.5 to E4.5 would be most appropriate to firmly establish when developmental defects arise.

We address the point of developmental delay by detailed staging of E2.5 embryos, using 42 control embryos (6 litters) and 44 maternally depleted *Ehmt2* embryos (8 litters) from natural matings. The analysis indicated a slight developmental delay already at E2.5 (see Figure 2---figure supplement 1; subsection "G9a promotes developmental progression and primitive endoderm (PrE) segregation", second paragraph and figure legend). Crucially, *Ehmt2^Mat^* embryos develop after 8C stage, and are morphologically indistinguishable from controls until morula stage, except this slight developmental delay. We have decided not to perform detailed staging at multiple developmental time points as it would require extensive number of mutant mice, which are currently beyond the scope of our animal facility capacities. Furthermore, we attempted to perform in vitro cultures of embryos from super-ovulated females throughout the preimplantation stages. However, from our preliminary experiments, we observed from 2C stage onwards, the phenotype of *Ehmt2^Mat^* becomes aggravated with multiple blastocysts developing entirely without the ICM. Therefore, we have concluded that extended in vitro culture would produce an artefactual phenotype.

> In Figure 1, authors state that at least 3 embryos and 15 nuclei used for analysis. These are very low numbers (embryos) to form reliable conclusions. They should increase the N numbers to cover at least 3 independent experiments and at least 10 embryos per group.

We have now greatly increased both the cell and embryo numbers (see Author response table 1 below). The data is in Figure 1 and a new Figure 1---figure supplement 1.
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> \- Immunostaining of H3K9me2 should also be performed at the 4-cell stage and morula stage to determine temporal dynamics of H3K9me2 in more detail. This is especially relevant in light of the results regarding derepression of 4-cell genes at the 8-cell stage in Ehmt2^Mat^ embryos in Figure 3. The model proposed is that G9a is silencing genes between the 4-cell and 8-cell stage specifically (not before), which correlates with a global accumulation of H3K9me2. However this accumulation is only presented between the 2-cell and 8-cell stages here in Figure 1, not the 4-cell and 8-cell stages. If global accumulation of H3K9me2 is in fact occurring most prominently between the 2-cell and 4-cell stages the model proposed does not hold.

We address this point by extending our IF analysis for G9a and H3K9me2 to the 4-cell stage (E2.0; at least 10 embryos analysed). We have included our new results in Figure 1 and for clarity moved GLP IF staining into Figure 1---figure supplement 1. We show start of G9a accumulation at the 4C stage, and significant increase at the 8C stage. The H3K9me2 accumulation follows a broadly similar trend at the 4C and 8C stage albeit the strongest accumulation is observed already at 4C stage, with a significant gain at 8C, which could partially be due to newly-targeted regions. Our combined data together with RNAseq analysis indicates that the H3K9me2 accumulation at the 4C stage might not initially extend to the 4C-specific genes, which probably becomes established at the 8C stage when G9a levels increase. This likely explains the robust derepression of 4C genes at the 8C stage (see subsection "G9a and H3K9me2 accumulate at 4 and 8-cell stage", last paragraph and subsection "G9a represses a subset of 4C upregulated genes", fourth paragraph).

> \- Also in Figure 2, only 4 embryos analysed, which is not enough for an appropriate analysis. At least 3 independent experiments (and at least 10 embryos per group) are required.

We have now analysed more embryos (N=6, see Figure 2B). The analysis clearly shows reduced H3K9me2 staining, already reported in our initial manuscript. A similar assay was used reported recently in *eLife* used as few as 5 embryos per genotype (see: (Ancelin et al., 2016) -- Figure 3.)

> \- The authors conclude that there are fewer ICM cells in G9a-deficient blastocysts based on counting of Oct4-positive cells. However this conclusion is not fully supported by the results presented here. Please explain how this experiment was performed.

We have used two different markers of pluripotency: Sox2 (Figure 2) and Oct4 GFP reporter (Figure 2---figure supplement 1). Note that Sox2 detects the pre-Epiblast at E4.5 and not the PrE (See: (Wicklow et al., 2014) -- Figure 3C); on the other hand, Oct4 detects both the pre-Epi and PrE (See: (Wicklow et al., 2014) -- Figure 6G). Thus, the presence of fewer Oct4+ve cells with a stable Sox2 positive cells is consistent with a loss of PrE cells, which is confirmed by analysis of the Sox17 positive PrE cells (Figure 2; see subsection "G9a promotes developmental progression and primitive endoderm (PrE) segregation" and Figure 2---figure supplement 1 legend).

> \- It would also be most informative to analyse these counts at both E3.5 as well as E4.5 to determine the timing of the effect (i.e. is ICM establishment at E3.5 or differentiation into PE vs. EPI at E4.5 affected in the absence of G9a?).

Our analysis thus far reveals relatively normal pre-Epiblast lineage specification, and defective delineation of the PrE at E4.5. The unaffected pre-Epiblast by necessity reflects normal specification of the ICM at E3.5, without which there would be neither pre-Epi nor PrE. In our opinion, the additional experiment asked by the reviewer is unlikely add enough further insight on the role of G9a in preimplantation development. Due to limited numbers of mutant animals and in accordance with the guidance in animal work (3Rs), we have decided not to perform the experiment.

> \- The authors state that the GO term most enriched in genes downregulated in Ehmt2^Mat^ 8C embryos is chromatin silencing, which can be entirely explained by altered levels of H2A, MacroH2A and H2A.J transcripts. It is hard to believe that the strongest GO term enrichment with a highly significant p value can be entirely explained by 3 transcripts. Can the authors provide additional discussion/evidence for this?

We thank the reviewers for pointing out this apparent contradiction. The confusion arises because the histone variants and canonical histones, are coded for by multiple loci. We have mapped only unique reads allowing us to quantify the expression of individual histone genes. In our dataset we have found downregulation of 18 histone genes coding for 3 histones (H2A, MacroH2A and H2A.J). All these genes belong to the Chromatin Silencing GO term (GO:0006342). Apart from these 18 genes only 2 others are also downregulated in mutant embryos and belong to this GO term (see detailed list of genes below). Thus, the observed 8.3 fold enrichment of this GO term is indeed almost entirely driven by histone upregulation. Additional confusion might come from the fact that in Figure 3---figure supplement 1C we have combined the expression of each histone variant originating from individual genes. We have now clarified this in the figure legend and subsection "G9a represses a subset of 4C upregulated genes", second paragraph.

List of downregulated genes associated with chromatin silencing GO:

DOT1-like, histone H3 methyltransferase (*S.cerevisiae*)(Dot1l)H2A histone family, member J(H2afj)H2A histone family, member Y(H2afy)histone cluster 1, H2ab(Hist1h2ab)histone cluster 1, H2ac(Hist1h2ac)histone cluster 1, H2ad(Hist1h2ad)histone cluster 1, H2ae(Hist1h2ae)histone cluster 1, H2af(Hist1h2af)histone cluster 1, H2ag(Hist1h2ag)histone cluster 1, H2ah(Hist1h2ah)histone cluster 1, H2ai(Hist1h2ai)histone cluster 1, H2ak(Hist1h2ak)histone cluster 1, H2an(Hist1h2an)histone cluster 1, H2ao(Hist1h2ao)histone cluster 1, H2ap(Hist1h2ap)histone cluster 2, H2aa1(Hist2h2aa1)histone cluster 2, H2aa2(Hist2h2aa2)histone cluster 2, H2ab(Hist2h2ab)histone cluster 2, H2ac(Hist2h2ac)trinucleotide repeat containing 18(Tnrc18)

> \- Authors should expand on their observations that there is increase DNA damage in the absence of maternal G9a. It was not clear why this is the case?

Indeed, this is an intriguing question. It is worth noting that gH2Ax is not only a marker of increased DNA damage, because it often accumulates in embryonic stem cells even without genotoxic stress (Banath et al., 2009). gH2AX also marks cells at specific cell cycle stages (e.g. G2), as well as in cells with relatively open chromatin (Banath et al., 2009; Turinetto and Giachino, 2015). We have now included additional discussion of these points (subsection "G9a promotes developmental progression and primitive endoderm (PrE) segregation", last paragraph).

> \- Is there a way to experimentally address whether gene expression defects are a result of direct targeting of G9a to the promoters?

There is no available dataset or G9a ChIPseq at E2.5, since no suitable protocols exists to perform such experiment on limited numbers of cells as in early embryos. Recent novel technologies allow for mapping the recruitment of some transcriptional factors in limited numbers of cells; however G9a is not suitable for such experiments as its binding is relatively dynamic and spreads over larger regions.

> \- It was interesting to see that G9a dispensable for transposon repression. Is it possible to know whether upon G9a loss, SETDB1 gets upregulated to compensate?

We have now explored this aspect in our RNAseq dataset. The results indicate that there is no significant upregulation of Setdb1 upon maternal loss of G9a (see [Author response image 1](#respfig1){ref-type="fig"}). This implies that G9a activity is not targeted to TEs; it is likely that Setdb1 plays this role.
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> Other points:
>
> 1\) Is the H3K9me2 antibody used specific for K9me2? Since most antibodies are known to cross-react with K9me3 and/or K9me1 -- it will be important that the authors discuss/provide a statement and/or data towards this effect.

The reviewers have pointed out that many of the histone-modification antibodies show substantial levels of cross reactivity. That is why we have used a monoclonal anti-H3K9me2 antibody (Abcam, ab1220), after validating it using dot-blot analysis (Active motif). There is no detectible cross-reactivity with either K9me1, or me3. [Author response image 2](#respfig2){ref-type="fig"} shows the specificity factor calculated using dot-blot quantification. Shown are top 10 marks recognised by this antibody, neither H3K9me1 nor me3 is showing detectable cross-reactivity.
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> 2\) For the presentation of confocal images:
>
> \- The scale bars are missing in a number of images (e.g. Figure 1A and B).

The missing scale bars are now added.

> \- How was fluorescence intensity quantification carried out?

Mean nuclear intensities of IF and DAPI signal were quantified using the imaging software Image J and corrected for the staining background. As nuclear size changes between stages, all IF measurements were normalised to DAPI signal as a proxy for DNA content. We have now added this description in the Materials and methods subsection "Immunofluorescence".

[^1]: These authors contributed equally to this work.
